Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (”Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today provided an update on its two patent ...
Aspire Biopharma provides update on recently filed U.S. patent applications
Holdings rovided an update on its two patent applications, originally filed as provisional patent applications with the ...
JD Supra9h
Validity Analysis for Product-by-Process Claim Focuses on Product
The US Court of Appeals for the Federal Circuit affirmed a Patent Trial & Appeal Board patentability finding, explaining that an anticipation ...
Rutgers University11h
Rutgers Rises in National Top 100 Worldwide Patent Ranking
Rutgers has been a fixture in the NAI Top 100 Worldwide Universities List, appearing in all 12 rankings since its inception ...
JD Supra12h
About Time! Steps You Should Consider to Protect Your Watch-Related Brand
As major watch industry events are fast approaching in 2025, it may be time for businesses to reevaluate or add to the tools at their disposal ...
13 Most Undervalued NASDAQ Stocks To Buy According To Hedge Funds
The NASDAQ Index closed more than 10% below its December high of 20,174 on March 6, 2025. This officially puts the index in a ...
Amarin Corporation plc (NASDAQ:AMRN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 12, 2025 Amarin Corporation plc beats earnings expectations. Reported EPS is $-0.03, ...